Your browser doesn't support javascript.
loading
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination.
Tomalka, Jeffrey Alan; Pelletier, Adam Nicolas; Fourati, Slim; Latif, Muhammad Bilal; Sharma, Ashish; Furr, Kathryn; Carlson, Kevin; Lifton, Michelle; Gonzalez, Ana; Wilkinson, Peter; Franchini, Genoveffa; Parks, Robert; Letvin, Norman; Yates, Nicole; Seaton, Kelly; Tomaras, Georgia; Tartaglia, Jim; Robb, Merlin L; Michael, Nelson L; Koup, Richard; Haynes, Barton; Santra, Sampa; Sekaly, Rafick Pierre.
Affiliation
  • Tomalka JA; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Pelletier AN; Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Fourati S; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Latif MB; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Sharma A; Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Furr K; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Carlson K; Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Lifton M; Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Gonzalez A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Wilkinson P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Franchini G; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Parks R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Letvin N; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Yates N; Center for Cancer Research Vaccine Branch, National Cancer Institute NIH, Bethesda, MD, USA.
  • Seaton K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Tomaras G; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Tartaglia J; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Robb ML; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Michael NL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Koup R; Sanofi-Pasteur, Swiftwater, PA, USA.
  • Haynes B; Military HIV Research Program, Henry Jackson Foundation and Walter Reed Army Institute for Research, Bethesda and Silver Spring, MD, USA.
  • Santra S; Military HIV Research Program, Henry Jackson Foundation and Walter Reed Army Institute for Research, Bethesda and Silver Spring, MD, USA.
  • Sekaly RP; Vaccine Research Center, National Institutes of Health, Bethesda, MD, USA.
Nat Immunol ; 22(10): 1294-1305, 2021 10.
Article in En | MEDLINE | ID: mdl-34556879
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Vaccines / HIV Infections / HIV-1 / Cyclic AMP Response Element-Binding Protein / Immunogenicity, Vaccine Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nat Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Vaccines / HIV Infections / HIV-1 / Cyclic AMP Response Element-Binding Protein / Immunogenicity, Vaccine Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nat Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Affiliation country: